Publication:
Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.

Loading...
Thumbnail Image

Date

2022-02-28

Authors

Cairat, Manon
Rinaldi, Sabina
Navionis, Anne-Sophie
Romieu, Isabelle
Biessy, Carine
Viallon, Vivian
Olsen, Anja
Tjønneland, Anne
Fournier, Agnès
Severi, Gianluca

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

BioMed Central Ltd.
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Inflammation has been hypothesized to play a role in the development and progression of breast cancer and might differently impact breast cancer risk among pre and postmenopausal women. We performed a nested case-control study to examine whether pre-diagnostic circulating concentrations of adiponectin, leptin, c-reactive protein (CRP), tumour necrosis factor-α, interferon-γ and 6 interleukins were associated with breast cancer risk, overall and by menopausal status. Pre-diagnostic levels of inflammatory biomarkers were measured in plasma from 1558 case-control pairs from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. We used conditional logistic regression to estimate the odds ratios (ORs) of breast cancer at blood collection, per one standard deviation increase in biomarker concentration. Cases were diagnosed at a mean age of 61.4 years on average 8.6 years after blood collection. No statistically significant association was observed between inflammatory markers and breast cancer risk overall. In premenopausal women, borderline significant inverse associations were observed for leptin, leptin-to-adiponectin ratio and CRP [OR= 0.89 (0.77-1.03), OR= 0.88 (0.76-1.01) and OR= 0.87 (0.75-1.01), respectively] while positive associations were observed among postmenopausal women [OR= 1.16 (1.05-1.29), OR= 1.11 (1.01-1.23), OR= 1.10 (0.99-1.22), respectively]. Adjustment for BMI strengthened the estimates in premenopausal women [leptin: OR = 0.83 (0.68-1.00), leptin-to-adiponectin ratio: OR = 0.80 (0.66-0.97), CRP: OR = 0.85 (0.72-1.00)] but attenuated the estimates in postmenopausal women [leptin: OR = 1.09 (0.96-1.24), leptin-to-adiponectin ratio: OR = 1.02 (0.89-1.16), CRP: OR = 1.04 (0.92-1.16)]. Associations between CRP, leptin and leptin-to-adiponectin ratio with breast cancer risk may represent the dual effect of obesity by menopausal status although this deserves further investigation.

Description

MeSH Terms

Adipokines
Adiponectin
Biomarkers
Body Mass Index
Breast Neoplasms
C-Reactive Protein
Case-Control Studies
Female
Humans
Leptin
Middle Aged
Prospective Studies
Risk Factors

DeCS Terms

Adiponectina
Adipoquinas
Biomarcadores
Estudios prospectivos
Estudios de casos y controles
Factores de riesgo
Leptina
Neoplasias de la mama
Persona de mediana edad
Proteína C-Reactiva
Índice de masa corporal

CIE Terms

Keywords

Anthropometry, Biomarkers, Breast cancer, Inflammation, Menopausal status

Citation

Cairat M, Rinaldi S, Navionis AS, Romieu I, Biessy C, Viallon V, et al. Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort. BMC Med. 2022 Apr 18;20(1):118.